Blood levels (ng/ml) | Oral dose (IU) | Treatment duration |
---|---|---|
Group A (target: 60 ng/ml): | ||
< 10 | 75 000 at study visit +4000/day | 3 months then re-evaluate |
> 10-20 | 50 000 at study visit +4000/day | 3 months then re-evaluate |
> 20-30 | 25 000 at study visit +4000/day | 3 months then re-evaluate |
> 30 | 4000/day | 3 months then re-evaluate |
60-80 | change to 1000 IU/day | 3 months then re-evaluate |
Group B (target: 30 ng/ml): | ||
≤ 10 | 100 000 at study visit | Re-evaluate after 3 months |
≤ 20 | 75 000 at study visit | Re-evaluate after 3 months |
> 20-25 | 50 000 at study visit | Re-evaluate after 3 months |
> 25-29 | 25 000 at study visit | Re-evaluate after 3 months |
≥ 30 | 0 | Re-evaluate after 3 months |